1 Min Read
Nov 9 (Reuters) - Eiger Biopharmaceuticals Inc
* Prosight Management reports a 6.9 percent passive stake in Eiger Biopharmaceuticals as of Oct 31 - SEC filing Source text: (bit.ly/2mbmToK) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.